ReutersReuters

Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Thursday:

** Global private equity firm Carlyle Group (3VU) is selling its stake in portfolio firm AmbioPharm Inc, targeting a valuation of $1 billion in a potential deal, two people familiar with the situation told Reuters.

** Swedish hygiene products maker Essity (ESSITY.ST) has agreed to buy Australian leakproof apparel maker Modibodi for 985 million Swedish crowns ($93.70 million), it said in a statement.

** Drugmaker Merck & Co (6MK) is in advanced talks to buy cancer-focused biotech company Seagen Inc (S1GE34) in a deal that could be worth roughly $40 billion or more, the Wall Street Journal reported on Wednesday.

** Australian casino operator Crown Resorts named operations head of Wynn Macau (WYNMY), Ciarán Carruthers, as its chief executive officer, replacing Steve McCann weeks after its $6.3-billion takeover by private equity Blackstone (BBN1).

** Australia's Link Administration (1LK) said it would consider a revised A$2.34 billion ($1.59 billion) base scheme takeover bid from Canadian cloud-based software firm Dye & Durham, after rejecting its lowered offer earlier this week.

** Australia's Bendigo and Adelaide Bank (BEN) (BEN) said it will buy larger peer Australia and New Zealand Banking Group's (ANB) investment lending portfolio to expand its margin lending business.

Tiếp tục đọc
Đăng nhập hoặc đăng ký tài khoản TradingView miễn phí và tận hưởng quyền truy cập vào tin tức tài chính toàn cầu theo thời gian thực.